Reach further, in an Open Access Journal Endocrinology, Diabetes & Metabolism Case Reports

ISSN 1470-3947 (print)
ISSN 1479-6848 (online)

Searchable abstracts of presentations at key conferences in endocrinology

Published by BioScientifica
Endocrine Abstracts (2010) 22 P604 

CB1 modulation of hormone secretion, neuronal activation and mRNA expression following blood volume expansion (BVE)

Silvia Ruginsk, Ernane Uchoa, Lucila Elias & Jose Antunes-Rodrigues

Author affiliations

The endocannabinoid system is involved in several homeostatic and neuroendocrine functions. In the present study, we evaluated the effects of type 1 cannabinoid (CB1) receptor antagonist, rimonabant (10 mg/kg, p.o.), on hormone secretion, neuronal activation and mRNA expression in the hypothalamus following isotonic (I−) or hypertonic (H−) blood volume expansion (BVE). Our results showed that the secretion of both oxytocin (OT) and vasopressin (AVP) were increased in response to H-BVE. Both I- and H-BVE stimulated oxytocinergic neuronal activation in the PVN and SON, although vasopressinergic cells were only activated in response to H-BVE. Accordingly, increased expression of both AVP and OT mRNAs were found in these nuclei following H-BVE. Pretreatment with rimonabant significantly potentiated hormone secretion and also vasopressinergic and oxytocinergic neuronal activation induced by BVE, although a decreased AVP and OT mRNA expression was found in the hypothalami of rimonabant pretreated groups. Taken together, these results suggest that the CB1 receptor may modulate several events that contribute to the development of appropriate responses to increased fluid volume and osmolality.

This Issue/Conference

Article tools

My recent searches